Lv1
40 积分 2025-11-08 加入
Orteronel plus prednisone in patients with chemotherapy-naive metastatic castration-resistant prostate cancer (ELM-PC 4): a double-blind, multicentre, phase 3, randomised, placebo-controlled trial
26天前
已完结
Justification for unequal allocation ratios in clinical trials: A scoping review
1个月前
已完结
CLSI POCT05 Performance Metrics for Continuous Interstitial Glucose Monitoring
1个月前
已关闭
Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial
2个月前
已完结
A safety estimand for late phase clinical trials where the analysis period varies over the subjects
2个月前
已完结
A safety estimand for late phase clinical trials where the analysis period varies over the subjects
3个月前
已完结
Operationalizing intermediate clinical endpoints: A pragmatic framework for prostate cancer management trials
3个月前
已完结
Acne vulgaris
4个月前
已完结
Atrasentan in Patients with IgA Nephropathy
4个月前
已完结
皖公网安备34019202002308
